130 related articles for article (PubMed ID: 37916144)
1. [Hypertensive Emergency as the Debut of Paraneoplastic Cushing Syndrome].
Rubio González E; de Valdenebro Recio M; Galán Fernández MI
Hipertens Riesgo Vasc; 2024; 41(2):135-138. PubMed ID: 38508875
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic Syndromes in Neuroendocrine Prostate Cancer: A Systematic Review.
Abufaraj M; Ramadan R; Alkhatib A
Curr Oncol; 2024 Mar; 31(3):1618-1632. PubMed ID: 38534956
[TBL] [Abstract][Full Text] [Related]
3. A Lung Cancer Patient Presenting With Gynecomastia: An Uncommon Paraneoplastic Syndrome.
Sanjan G; Banerjee S; Dua R; Sharma P
Cureus; 2024 Feb; 16(2):e54758. PubMed ID: 38523990
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary neuroendocrine tumors : Current review].
Meyer HJ; Frille A; Tiepolt S; Denecke T
Radiologie (Heidelb); 2024 May; ():. PubMed ID: 38806730
[TBL] [Abstract][Full Text] [Related]
5. Management of small cell lung cancer complicated with paraneoplastic Cushing's syndrome: a systematic literature review.
Li Y; Li C; Qi X; Yu L; Lin L
Front Endocrinol (Lausanne); 2023; 14():1177125. PubMed ID: 37916144
[TBL] [Abstract][Full Text] [Related]
6. Long-term Survival of a Patient with Small Cell Lung Cancer Secreting ADH and ACTH Simultaneously, Following the Prolonged Use of Amrubicin.
Kosuda A; Shirahata T; Kudo N; Uehara Y; Miyawaki M; Hagiwara A; Murakami R; Shimizu K
Intern Med; 2020 Jan; 59(1):107-112. PubMed ID: 31511478
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing's syndrome.
Auchus RJ; Mastorakos G; Friedman TC; Chrousos GP
J Endocrinol Invest; 1994 Jun; 17(6):447-52. PubMed ID: 7930390
[TBL] [Abstract][Full Text] [Related]
8. Ectopic production of ACTH and corticotropin-releasing hormone (CRH).
Müller OA; von Werder K
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):403-8. PubMed ID: 1327073
[TBL] [Abstract][Full Text] [Related]
9. Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature.
Corsello A; Ramunno V; Locantore P; Pacini G; Rossi ED; Torino F; Pontecorvi A; De Crea C; Paragliola RM; Raffaelli M; Corsello SM
Thyroid; 2022 Nov; 32(11):1281-1298. PubMed ID: 35833793
[No Abstract] [Full Text] [Related]
10. Development of Cushing's syndrome during effective chemotherapy for small cell lung cancer.
Suyama K; Naito Y; Yoh K; Niho S; Goto K; Ohmatsu H; Nishiwaki Y; Ohe Y
Intern Med; 2011; 50(4):335-8. PubMed ID: 21325767
[TBL] [Abstract][Full Text] [Related]
11. SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection.
Wang Q; Gümüş ZH; Colarossi C; Memeo L; Wang X; Kong CY; Boffetta P
J Thorac Oncol; 2023 Jan; 18(1):31-46. PubMed ID: 36243387
[TBL] [Abstract][Full Text] [Related]
12. Is ectopic Cushing's syndrome underdiagnosed in patients with small cell lung cancer?
Piasecka M; Larsson M; Papakokkinou E; Olsson L; Ragnarsson O
Front Med (Lausanne); 2022; 9():954033. PubMed ID: 36111117
[TBL] [Abstract][Full Text] [Related]
13. Endocrine immune-related adverse events: Adrenal, parathyroid, diabetes insipidus, and lipoatrophy.
Atkinson M; Lansdown AJ
Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101635. PubMed ID: 35382989
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
